P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation
Status: | Recruiting |
---|---|
Conditions: | Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 22 - 75 |
Updated: | 2/6/2019 |
Start Date: | April 24, 2018 |
End Date: | September 30, 2025 |
Contact: | Roger White |
Email: | rwhite@cerapedics.com |
Phone: | 303-550-2451 |
An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation
The aim of this trial is to evaluate if P-15L bone graft (investigational device) is not
inferior in effectiveness and safety to local autologous bone (and allograft where necessary)
as an extender (control device) when applied in instrumented transforaminal lumbar interbody
fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general
overall objective, a sub-group analysis will be performed on the high-risk subject population
(tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking,
obesity and diabetes on fusion and bone healing, increased peri/postoperative complications,
and lower patient-reported outcome scores.
inferior in effectiveness and safety to local autologous bone (and allograft where necessary)
as an extender (control device) when applied in instrumented transforaminal lumbar interbody
fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general
overall objective, a sub-group analysis will be performed on the high-risk subject population
(tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking,
obesity and diabetes on fusion and bone healing, increased peri/postoperative complications,
and lower patient-reported outcome scores.
Inclusion Criteria (abbreviated):
Skeletally mature adults between 22 and 75 years old (inclusive);
Back pain with radicular symptoms as evidenced by leg pain, confirmed by history and
physical exam;
Oswestry Low Back Pain Disability Questionnaire score of ≥ 35;
Involved disc(s) between L2 and S1;
Exclusion Criteria (abbreviated):
Significant metabolic disease that in the surgeon's opinion might compromise bone growth
such as osteoporosis, osteopenia, or osteomalacia;
Active malignancy;
Nondiscogenic source of symptoms (e.g. tumor, etc.);
Multiple level symptomatic degenerative disc disease;
Previous spinal instrumentation or a previous interbody fusion procedure at the involved
level;
More than one level to be operated;
We found this trial at
22
sites
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Click here to add this to my saved trials
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
Click here to add this to my saved trials
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials